Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder

Phillip H. Abbosh, Mingsheng Wang, John N. Eble, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi, Suqin Zheng, Chong-Xian Pan, Honghong Zhou, Liang Cheng

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Small-cell carcinoma of the urinary bladder (SCBC) is a rare tumor, which shows a common clonal origin with urothelial carcinoma. It bears a high metastatic potential, even when discovered in a localized state. Identifying the molecular underpinnings of this disease may elucidate useful clinical information regarding prevention, diagnosis, prognosis, treatment, and surveillance. As DNA methylation is widely recognized as having a pivotal role in the process of carcinogenesis, we analyzed the DNA methylation status of four frequently hypermethylated tumor suppressors in small-cell and transitional-cell carcinoma (TCC) arising concomitantly in 13 patients. Fourteen cases of pure TCC were also included in the analysis. We identified frequent methylation of RASSF1 and MGMT and infrequent methylation of MLH1 and DAPK1 in cases of concomitant TCC and SCBC. Similar rates of methylation were found in pure and concomitant histopathologies, with the exception of MGMT, which was much less frequently methylated in pure TCC. These findings suggest that SCBC and TCC have common origins, establish DNA methylation of some tumor suppressors as frequent occurrences in both histopathologies, and suggest that MGMT methylation may be an SCBC-specific epimutation.

Original languageEnglish (US)
Pages (from-to)355-362
Number of pages8
JournalModern Pathology
Volume21
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

CpG Islands
Small Cell Carcinoma
Transitional Cell Carcinoma
Tumor Suppressor Genes
Urinary Bladder
Methylation
DNA Methylation
Neoplasms
Carcinogenesis
Carcinoma

Keywords

  • DNA methylation
  • Epigenetics
  • Small-cell carcinoma
  • Urinary bladder

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Abbosh, P. H., Wang, M., Eble, J. N., Lopez-Beltran, A., MacLennan, G. T., Montironi, R., ... Cheng, L. (2008). Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Modern Pathology, 21(3), 355-362. https://doi.org/10.1038/modpathol.3801012

Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. / Abbosh, Phillip H.; Wang, Mingsheng; Eble, John N.; Lopez-Beltran, Antonio; MacLennan, Gregory T.; Montironi, Rodolfo; Zheng, Suqin; Pan, Chong-Xian; Zhou, Honghong; Cheng, Liang.

In: Modern Pathology, Vol. 21, No. 3, 03.2008, p. 355-362.

Research output: Contribution to journalArticle

Abbosh, PH, Wang, M, Eble, JN, Lopez-Beltran, A, MacLennan, GT, Montironi, R, Zheng, S, Pan, C-X, Zhou, H & Cheng, L 2008, 'Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder', Modern Pathology, vol. 21, no. 3, pp. 355-362. https://doi.org/10.1038/modpathol.3801012
Abbosh PH, Wang M, Eble JN, Lopez-Beltran A, MacLennan GT, Montironi R et al. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Modern Pathology. 2008 Mar;21(3):355-362. https://doi.org/10.1038/modpathol.3801012
Abbosh, Phillip H. ; Wang, Mingsheng ; Eble, John N. ; Lopez-Beltran, Antonio ; MacLennan, Gregory T. ; Montironi, Rodolfo ; Zheng, Suqin ; Pan, Chong-Xian ; Zhou, Honghong ; Cheng, Liang. / Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. In: Modern Pathology. 2008 ; Vol. 21, No. 3. pp. 355-362.
@article{53f5c2efbca9412695660b37dd41ebb3,
title = "Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder",
abstract = "Small-cell carcinoma of the urinary bladder (SCBC) is a rare tumor, which shows a common clonal origin with urothelial carcinoma. It bears a high metastatic potential, even when discovered in a localized state. Identifying the molecular underpinnings of this disease may elucidate useful clinical information regarding prevention, diagnosis, prognosis, treatment, and surveillance. As DNA methylation is widely recognized as having a pivotal role in the process of carcinogenesis, we analyzed the DNA methylation status of four frequently hypermethylated tumor suppressors in small-cell and transitional-cell carcinoma (TCC) arising concomitantly in 13 patients. Fourteen cases of pure TCC were also included in the analysis. We identified frequent methylation of RASSF1 and MGMT and infrequent methylation of MLH1 and DAPK1 in cases of concomitant TCC and SCBC. Similar rates of methylation were found in pure and concomitant histopathologies, with the exception of MGMT, which was much less frequently methylated in pure TCC. These findings suggest that SCBC and TCC have common origins, establish DNA methylation of some tumor suppressors as frequent occurrences in both histopathologies, and suggest that MGMT methylation may be an SCBC-specific epimutation.",
keywords = "DNA methylation, Epigenetics, Small-cell carcinoma, Urinary bladder",
author = "Abbosh, {Phillip H.} and Mingsheng Wang and Eble, {John N.} and Antonio Lopez-Beltran and MacLennan, {Gregory T.} and Rodolfo Montironi and Suqin Zheng and Chong-Xian Pan and Honghong Zhou and Liang Cheng",
year = "2008",
month = "3",
doi = "10.1038/modpathol.3801012",
language = "English (US)",
volume = "21",
pages = "355--362",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder

AU - Abbosh, Phillip H.

AU - Wang, Mingsheng

AU - Eble, John N.

AU - Lopez-Beltran, Antonio

AU - MacLennan, Gregory T.

AU - Montironi, Rodolfo

AU - Zheng, Suqin

AU - Pan, Chong-Xian

AU - Zhou, Honghong

AU - Cheng, Liang

PY - 2008/3

Y1 - 2008/3

N2 - Small-cell carcinoma of the urinary bladder (SCBC) is a rare tumor, which shows a common clonal origin with urothelial carcinoma. It bears a high metastatic potential, even when discovered in a localized state. Identifying the molecular underpinnings of this disease may elucidate useful clinical information regarding prevention, diagnosis, prognosis, treatment, and surveillance. As DNA methylation is widely recognized as having a pivotal role in the process of carcinogenesis, we analyzed the DNA methylation status of four frequently hypermethylated tumor suppressors in small-cell and transitional-cell carcinoma (TCC) arising concomitantly in 13 patients. Fourteen cases of pure TCC were also included in the analysis. We identified frequent methylation of RASSF1 and MGMT and infrequent methylation of MLH1 and DAPK1 in cases of concomitant TCC and SCBC. Similar rates of methylation were found in pure and concomitant histopathologies, with the exception of MGMT, which was much less frequently methylated in pure TCC. These findings suggest that SCBC and TCC have common origins, establish DNA methylation of some tumor suppressors as frequent occurrences in both histopathologies, and suggest that MGMT methylation may be an SCBC-specific epimutation.

AB - Small-cell carcinoma of the urinary bladder (SCBC) is a rare tumor, which shows a common clonal origin with urothelial carcinoma. It bears a high metastatic potential, even when discovered in a localized state. Identifying the molecular underpinnings of this disease may elucidate useful clinical information regarding prevention, diagnosis, prognosis, treatment, and surveillance. As DNA methylation is widely recognized as having a pivotal role in the process of carcinogenesis, we analyzed the DNA methylation status of four frequently hypermethylated tumor suppressors in small-cell and transitional-cell carcinoma (TCC) arising concomitantly in 13 patients. Fourteen cases of pure TCC were also included in the analysis. We identified frequent methylation of RASSF1 and MGMT and infrequent methylation of MLH1 and DAPK1 in cases of concomitant TCC and SCBC. Similar rates of methylation were found in pure and concomitant histopathologies, with the exception of MGMT, which was much less frequently methylated in pure TCC. These findings suggest that SCBC and TCC have common origins, establish DNA methylation of some tumor suppressors as frequent occurrences in both histopathologies, and suggest that MGMT methylation may be an SCBC-specific epimutation.

KW - DNA methylation

KW - Epigenetics

KW - Small-cell carcinoma

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=39749128356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749128356&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3801012

DO - 10.1038/modpathol.3801012

M3 - Article

C2 - 18192966

AN - SCOPUS:39749128356

VL - 21

SP - 355

EP - 362

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 3

ER -